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Most E3 ligases use a RING domain to activate a
thioester-linked E2ubiquitin-like protein (UBL) in-
termediate and promote UBL transfer to a remotely
bound target protein. Nonetheless, RING E3 mecha-
nisms matching a specific UBL and acceptor lysine
remain elusive, including for RBX1, which mediates
NEDD8 ligation to cullins and >10% of all ubiquitina-
tion. We report the structure of a trapped RING
E3-E2UBL-target intermediate representing RBX1-
UBC12NEDD8-CUL1-DCN1, which reveals the
mechanism of NEDD8 ligation and how a particular
UBL and acceptor lysine arematched by amultifunc-
tional RING E3. Numerousmechanisms specify cullin
neddylation while preventing noncognate ubiquitin
ligation. Notably, E2-E3-target and RING-E2UBL
modulesare not optimized to function independently,
but instead require integration by the UBL and target
for maximal reactivity. The UBL and target regulate
the catalytic machinery by positioning the RING-
E2UBL catalytic center, licensing the acceptor
lysine, and influencing E2 reactivity, thereby driving
their specific coupling by a multifunctional RING E3.
INTRODUCTION
Ubiquitin-like protein (UBL) modification is a key eukaryotic
mechanism for regulating protein function. For example, ubiqui-
tin (UB) and SUMO are ligated either individually or as polyUB or
polySUMO chains to a massive segment of the proteome, trans-
forming target properties such as half-life, subcellular localiza-
tion, or intermolecular interactions. By contrast, the UBL
NEDD8 is exceptionally selective and chiefly modifies closely
related cullin proteins (CULs) on a single conserved lysine.
CULs constitutively associate with an RBX RING E3 and
nucleate the Cullin-RING UB Ligase (CRL) superfamily. By stim-ulating CRL activity and assembly, NEDD8 ligation to CULs con-
trols z10%–20% of all cellular ubiquitination (Soucy et al.,
2009). Notably, an inhibitor of NEDD8 conjugation is in anti-
cancer clinical trials (Soucy et al., 2009) and also counteracts
Vif-dependent HIV infectivity (Stanley et al., 2012).
Given the distinct functions of different UBL modifications,
and the therapeutic potential for modulating their conjugation,
a central challenge is to determine how a particular UBL is
matched with a specific target. This involves cascades of
E1, E2, and E3 enzymes. An E1-activated UBL is loaded onto
an E2 catalytic cysteine, producing a transient thioester-bonded
E2UBL intermediate (here, covalent interactions are denoted
with ‘‘,’’ noncovalent complexes with ‘‘’’). Most E3s, including
z600 predicted RING E3s in humans, interact with dedicated
subsets amongz30 E2UBL intermediates to promote transfer
of a UBL’s C terminus from an E2 active site to a target’s
acceptor lysine or N terminus (here, this aminolysis reaction pro-
ducing an isopeptide-bonded UBLtarget complex is termed
‘‘ligation’’; the UBL to be transferred is ‘‘donor’’ and site of liga-
tion is ‘‘acceptor’’) (Deshaies and Joazeiro, 2009; Metzger et al.,
2014).
Current models posit that RING E3s are modular molecular
machines (Deshaies and Joazeiro, 2009; Metzger et al., 2014):
a protein interaction domain engages a motif distal from the
acceptor lysine in the target protein, and a RING domain recruits
and activates an E2UBL intermediate. E3 RING and non-RING
elements, the E2, and the donor UB interact with each other
through surfaces remote from the active site to stabilize a closed
E2UB conformation that immobilizes and primes the thioester
bond for nucleophilic attack (Dou et al., 2012b, 2013; Plechano-
vova´ et al., 2012; Pruneda et al., 2012). Within a RING E3-
substrate complex, the RING domain, substrate-binding
domain, and different domains within a substrate can rotate
relative to each other. Thus, RING E3s are thought to loosely
connect the remotely bound substrate to the activated RING-
E2UBL intermediate (Deshaies and Joazeiro, 2009; Metzger
et al., 2014).
Paradigms for E2 selection of target lysines have been estab-
lished by a few studies of SUMOylating and polyubiquitinatingCell 157, 1671–1684, June 19, 2014 ª2014 Elsevier Inc. 1671
E2s that generally choose acceptor lysines by recognizing
surrounding side chains. Structures of the SUMO E2, UBC9,
bound to the target RanGAP also revealed E2 side chains
directly binding the acceptor lysine and accelerating catalysis
(Bernier-Villamor et al., 2002; Reverter and Lima, 2005; Yunus
and Lima, 2006). One of these, an aspartate, is missing from
the polyubiquitinating E2 UBE2S and the corresponding function
is instead mediated by a glutamate proximal to the acceptor
Lys11 in its target Ub (Wickliffe et al., 2011). A different mecha-
nism is used by the E2 UBC13: a rigid adaptor protein places
UB’s acceptor Lys63 at the active site (Eddins et al., 2006).
This raises the question of whether the numerous uncharacter-
ized RING E3s and E2s use similar or divergent mechanisms
for acceptor lysine targeting. Also, many RINGE3s aremultifunc-
tional, interacting with different E2s to modify distinct targets, to
transfer different UBLs, and/or to separately initiate and elongate
UB chains (Deshaies and Joazeiro, 2009; Metzger et al., 2014).
How a multifunctional RING E3 could steer a particular
E2UBL toward its specific substrate acceptor lysine(s) remains
elusive.
RBX1 is a multifunctional RING E3 that acts sequentially with
three E2s (UBC12, UBCH5, CDC34) to modify distinct targets
with either NEDD8 or UB (Duda et al., 2011; Zimmerman et al.,
2010). For simplification, we describe activities of human RBX1
associated with CUL1 to represent RBX-CUL complexes. First,
RBX1 promotes NEDD8 ligation to Lys720 in the ‘‘WHB subdo-
main’’ of CUL1’s C-terminal domain (CTD). Here, RBX1’s N-ter-
minal domain, a b strand constitutively anchored in CUL1’s CTD,
is the substrate-binding domain. RBX1’s C-terminal RING,
essential for cullin neddylation, binds and activates the
UBC12NEDD8 intermediate. A co-E3, DCN1, enhances this
reaction by its PONY domain (DCN1P) binding CUL1 and
UBC12’s acetylated N terminus (Kim et al., 2008; Kurz et al.,
2008; Monda et al., 2013; Scott et al., 2010, 2011). When assem-
bled with NEDD8-modified CUL1 and one of 69 different human
F-box proteins into a neddylated ‘‘SCF’’ type of CRL E3, RBX1
promotes UB transfer from the Cys of either UBCH5 or CDC34
to a substrate recruited to the F-box protein (Jin et al., 2004;
Wu et al., 2010). Finally, in the NEDD8-modified SCF, RBX1
collaborates with CDC34UB to mediate processive substrate
polyubiquitination (Kleiger et al., 2009b; Pierce et al., 2009).
CRL regulation, and NEDD8 and UB ligase activities, depends
on a flexible linker connecting RBX1’s N-terminal and RING
domains, allowing different relative domain orientations for
different functions. Six prior structures showed the RING pack-
ing against the CUL’s WHB subdomain (Angers et al., 2006;
Duda et al., 2008; Fischer et al., 2011; Goldenberg et al., 2004;
Zheng et al., 2002). While this RING conformation enables bind-
ing to the neddylation inhibitor/F-box protein exchange factor
CAND1, it is catalytically inactive: docking an E2 on RBX1’s
RING places the E2 active site >30 A˚ from CUL1’s acceptor
Lys720 and >50 A˚ from an F-box protein bound substrate
(Duda et al., 2008; Saha and Deshaies, 2008; Yamoah et al.,
2008). For neddylation, modeling UBC12 on a CUL1CTD-RBX1
structure (3RTR) with a reoriented RING revealed UBC12’s
active site close to but displaced from CUL1’s acceptor
Lys720 and did not provide a mechanism juxtaposing CUL1’s
Lys720 and UBC12’s active site (Calabrese et al., 2011). Struc-1672 Cell 157, 1671–1684, June 19, 2014 ª2014 Elsevier Inc.tures with neddylated CUL5CTD (3DQV) showed relative reloca-
tion of the neddylated cullin WHB and rotation of RBX1’s
RING, although it is not known how the RBX1-E2UB module
would be directed to a ubiquitination substrate (Duda et al.,
2008). Thus, how any active RBX1-E2UBL-substrate confor-
mation is achieved remains incompletely understood. Indeed,
there is no structure of any RING or RING-like E3-E2UBL-sub-
strate complex—cullin or otherwise—showing structural mecha-
nisms by which a RING E3 promotes adjoining a specific donor
UBL and substrate acceptor lysine.
Here, we address this problem and define the mechanism
of NEDD8 ligation to CUL1 with a crystal structure repre-
senting an RBX1-UBC12NEDD8-CUL1-DCN1 intermediate.
This structure of a RING E3 trapped as if mediating UBL ligation
also provides a framework for understanding RING E3 ligation
specificity.
RESULTS
UBL and Acceptor Lys Specificity in RBX1-Mediated
CUL1 Modification
NEDD8 ligation to the acceptor Lys720 is recapitulated for RBX1
bound to CUL1CTD, even in the absence of DCN1 (Huang et al.,
2009). We used this to test paradigms for RING E3 ligation. We
first asked if RBX1 stimulates UBC12NEDD8 ligation via a
canonical catalytic ‘‘linchpin’’ identified in E3-UBCH5UB
structures, where a RING arginine cements the E2 UBCH5 and
UB in the closed, active conformation (Figure 1A) (Dou et al.,
2012b, 2013; Plechanovova´ et al., 2012; Pruneda et al., 2012).
Ala mutation of RBX1’s corresponding Asn98 had no effect in
pulse-chase assays of NEDD8 transfer fromUBC12 to CUL1CTD,
while N98R impaired neddylation (Figure 1B). To test if this is
specific for neddylation and if RBX1 activates UBCH5UB
through canonical mechanisms, we performed parallel experi-
ments based on RBX1 promoting UB ligation from UBCH5 to
CUL1 in vitro, albeit over minutes under conditions where
CUL1 is neddylated within seconds (Duda et al., 2008; Wu
et al., 2003a). Interestingly, reactions with UBCH5UB dis-
played opposite mutational effects: N98A reduced and N98R
stimulated UB ligation efficiency, consistent with RING-
UBCH5UB structures (Figure 1C). Comparing RBX1-mediated
CUL1 modification with UBC12NEDD8 and UBCH5UB side-
by-side suggested: (1) RBX1 uses a variant mechanism to sta-
bilize an active UBC12NEDD8 intermediate, (2) the RBX1
RING is not optimized for UBCH5UB ligation to a cullin, and
(3) RBX1 is more efficient at promoting CUL1 modification by
UBC12NEDD8 than UBCH5UB.
Are the different transfer efficiencies of UBC12NEDD8
and UBCH5UB toward CUL1 explained by a ‘‘central dogma’’
of the UB/UBL field—that cognate E1-E2-E3 enzymes are
responsible for matching a UBL with its specific target? RBX1
and UBC12 sequences are distinctive among RINGs and E2s,
respectively, whereas NEDD8 is 100% identical to UB in key
residues defined by RING-UBCH5UB structures (Figure 1A).
However, we obtained surprising results upon assaying RBX1-
mediated CUL1CTD modification by a series of noncognate
E2UBL intermediates—UBC12UB, UBC12UB (R72A), and
UBCH5NEDD8 (A72R)—generated with altered-specificity
Figure 1. Specificity of RBX1-Mediated NEDD8 Ligation to CUL1
(A) Canonical RING-E2UB architecture, highlighting the linchpin and conservation of E2 and RING binding residues in UB and NEDD8, shown for CBL-
UBCH5UB (Dou et al., 2013).
(B) Mutational analysis of RBX1’s Asn98, corresponding to canonical RING linchpin, in RBX1-mediated pulse-chase fluorescent NEDD8 transfer from UBC12 to
CUL1CTD. Graph, rate compared to wild-type (WT) RBX1; error, 1 SD.
(C) Mutational analysis of RBX1’s Asn98, aka canonical RING linchpin, in RBX1-mediated pulse-chase fluorescent UB transfer fromUBCH5B to CUL1CTD. Graph,
rate compared to WT RBX1; error, 1 SD.
(D) Role of UBL in RBX1-mediated CUL1 modification assayed by comparing pulse-chase NEDD8, UB, or UB R72A transfer from NEDD8’s E2 UBC12. The
noncognate UBLUBwas loaded on UBC12 in the pulse reaction either through its R72Amutation or use of E1mutant UBA3 R190Q. Graph, rate compared toWT
UBC12NEDD8; error, 1 SD.
(E) Role of UBL in RBX1-mediated CUL1modification assayed by comparing UB or NEDD8 A72R transfer fromUBCH5B to CUL1CTD. The NEDD8 A72Rmutation
allows loading this noncognate UBL on UBCH5B in the pulse reaction. Graph, rate compared to WT UBCH5UB; error, 1 SD.
(F) CUL1CTD Lys locations. Docking RBX1’s RING from prior structures with that from CBL-UBCH5UB revealed a >30 A˚ gap between the active site and K720
(red) or other lysines (native in magenta, introduced in yellow) in CUL1 (Dou et al., 2013; Zheng et al., 2002).
(G) Acceptor Lys specificity for NEDD8 transfer from UBC12 to CUL1CTD or Lys mutants. Gly-Gly-Lys, appended to C terminus of CUL1CTD K720A.
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Figure 2. Structure of RBX1-UBC12NEDD8-CUL1CTD-DCN1P—A RING E3 in Action
(A) Structure of neddylation complex as cartoon, with active site and CUL1 acceptor residue 720 in red, and RBX1 ‘‘linchpin, lever, and pivot’’ spheres in center
panel.
(B) Surface representation. Inset: model of catalytic center.
See also Figure S1 and Movie S1.mutants. (NEDD8’s E1 or the R190Q mutant load UBC12 with
UB R72A or UB, respectively, and UB’s E1 loads UBCH5
with NEDD8 A72R; see Supplemental Information) Ligation
efficiencies of UBC12UB and UBC12UB (R72A) were sub-
stantially reduced (Figure 1D). In striking contrast, NEDD8
(A72R) enabled efficient ligation from UBCH5 (Figure 1E). Thus,
counter to current dogma, the identity of the UBL dictates
specificity of RBX1-mediated ligation from UBC12 or UBCH5
to a cullin.
Finally, we considered the basis for lysine targeting by NEDD8.
Although mutation of CUL1’s Lys720 suppresses neddylation,
one trivial explanation may be that other CUL1 lysines are
spatially inaccessible (Figure 1F). However, introduction of
lysines surrounding the K720A substitution, or appending Gly-
Gly-Lys to the C terminus nearby, also fails to rescue CUL1CTD
neddylation (Figure 1G). Thus, mechanisms precisely matching
a particular UBL and target remain elusive.
RBX1-UBC12NEDD8-CUL1-DCN1 Structure Trapped
in Action
To decipher a mechanism for RING E3-mediated UBL-substrate
pairing and the basis for cullin neddylation, we determined the
crystal structure of a stabilized version of a NEDD8 ligation inter-
mediate at 3.1 A˚ resolution (Figure 2, Figure S1 available online;1674 Cell 157, 1671–1684, June 19, 2014 ª2014 Elsevier Inc.Movie S1). NEDD8’s C terminus is covalently linked to a Ser
replacing the catalytic Cys111 in a modified UBC12 (Scott
et al., 2011; Wu et al., 2003b). The oxyester-bonded
UBC12NEDD8 intermediate was stable in complex with
RBX1, DCN1P, and CUL1CTD harboring a K720R mutation to
prevent NEDD8 transfer. Notably, relative to prior RBX1-CUL
structures, the RING domain is reoriented in a unique architec-
ture for NEDD8 ligation.
The heart of the complex is the active site, in which the
UBC12NEDD8 covalent linkage and CUL1 target site are juxta-
posed and sequestered within UBC12’s catalytic center (Fig-
ure 2A). A modeled CUL1 acceptor lysine’s ε-amino group is
poised for ligation at 2.6 A˚ from NEDD8’s C-terminal carbon
(Figure 2B).
The means by which UBC12NEDD8 is steered to the CUL1
acceptor differs from previously described mechanisms where
an E2 directly recruits a substrate (Bernier-Villamor et al., 2002;
Wickliffe et al., 2011). Here, side chain contacts between
UBC12 and CUL1 are sparse and there was little effect of
mutating side chains at the UBC12-CUL1 interface, with the
exception of UBC12’s Arg116 hydrogen bonding to the back-
bone of CUL1’s penultimate Leu775 (Figure S1D).
Below, we compare catalytic modules for neddylation with
those defined for SUMOylation and ubiquitination and discuss
how the ligation architecture is achieved by NEDD8 steering the
E3-E2UBL active site to CUL1, CUL1 structure licensing the
acceptor Lys720, and the properly positioned acceptor lysine
toggling E2 reactivity to promote NEDD8 transfer.
Distinctive Features of Catalytic Modules Contribute to
Ligation and Specificity
The RBX1 RING assembly with the catalytic core domain from
UBC12 and its covalently linked NEDD8 broadly resembles other
E3-E2UBL complexes primed for ligation (Dou et al., 2012b,
2013; Plechanovova´ et al., 2012; Pruneda et al., 2012; Reverter
and Lima, 2005), with distinct features contributing specificity.
UBC12NEDD8 adopts its own variation of the closed confor-
mation (Figure 3A). UBC12’s Asn113 fixes NEDD8’s C-terminal
tail, and UBC12’s Tyr130 in the E2 core domain contacts
NEDD8’s Ile44 (Figures 3B and 3C). Although RING-UBCH5UB
intermediates display analogous alignment of UB’s C-terminal
tail by UBCH5’s Asp87, and similar covalent linkage to
UBCH5, UB’s globular domain is relatively displaced: UB’s
Ile44 contacts UBCH5’s Ser108, which corresponds to
UBC12’s Tyr134 a helical turn from Tyr130. Each E2UBL inter-
mediate’s own closed conformation is important for ligation, as
revealed by the relative locations of compensatory mutant pairs:
E2 Leu mutants projecting methyl groups into the interface can
compensate for those removed by corresponding UBL I44A
mutations (Saha et al., 2011). UBC12 Y130L and UBCH5B
S108L mutations rescue NEDD8 or UB I44A mutations, respec-
tively (Figures 3D and 3E).
Similar binding between NEDD8 and UB to RING domains,
coupled with different relative orientations of the UBL globular
domains and E2s, leads to subtle variation in active site pre-
sentations, which appears to influence acceptor Lys recognition.
Comparing different E2UBL active sites (typically cysteines but
in structuresmutated to Ser or Lys) shows UBLC-termini aligned
but the opposing surface relatively displaced (Figures 3F and 3G)
(Dou et al., 2012b; Plechanovova´ et al., 2012; Reverter and Lima,
2005; Yunus and Lima, 2006). Amodeled CUL1 acceptor lysine’s
ε-amino group contacts the UBC12NEDD8 oxyester bond and
the backbone carbonyl but not the side chain from UBC12’s
Asp143. However, prior structures showed UBC9’s Asp side
chain contacting the acceptor Lys, a configuration paralleled in
models with UBCH5. As with the important role for UBCH5’s
Asp87 in ubiquitination, mutation of UBC12’s Asn113, which
aligns NEDD8’s C-terminal tail, impairs ligation. Neddylation is
not substantially affected for UBC12D143A (Figure 3H), whereas
the corresponding Asp is essential for ligation of SUMObyUBC9
and of UB by UBCH5.
The RBX1 RING binds UBC12NEDD8 via a largely
canonical RING-E2UBL interface, consistent with mutation
and NMR data (Calabrese et al., 2011; Huang et al., 2009).
However, RBX1’s Asn98 corresponding to the canonical
‘‘linchpin’’ does not contact UBC12. Furthermore, a modeled
canonical linchpin Arg would repel UBC12’s Lys120, explaining
why the RBX1 N98R mutation hinders neddylation (Figures 1B,
3I, and S2A).
How then, does RBX1’s RING activate? A distinct linchpin is
located on the opposite side of the RING domain: RBX1’s
Arg46, conserved among RBXs across evolution, ‘‘glues’’NEDD8’s b1-b2 loop (residues 7–10) to the back and base of
UBC12 (Figures 3I and 3J). Indeed, mutating RBX1’s Arg46,
or NEDD8’s Leu8 and Thr9 from the b1-b2 loop, hinders neddy-
lation (Figures 3K and 3L). The alternative linchpin location may
enable RBX1 to cater to individual features of multiple cognate
E2s (Figure S2B). Although future studies will be required to
overcome challenges of neddylating the RBX1 R46A mutant
to test its effects on SCF ubiquitination, this RBX1 region was
implicated by NMR as binding to CDC34UB (Spratt et al.,
2012). Furthermore, modeling an RBX1 complex with CDC34
in place of UBC12 shows potential for an acidic loop essential
for CDC34-mediated UB ligation to clash with a canonical
linchpin (Duda et al., 2012; Huang et al., 2014; Petroski and
Deshaies, 2005; Spratt et al., 2012; Ziemba et al., 2013). Accord-
ingly, despite its role in activating UBCH5UB, the N98R sub-
stitution in RBX1 impairs UB ligation from CDC34 (Figures
S2C–S2E).
NEDD8Directs an RBX1 Lever to Steer the Active Site to
the CUL1 Acceptor Lysine
The catalytic assembly is organized by three-way interactions
between RBX1, UBC12’s E2 core domain, and its covalently
linked NEDD8. A key feature is that NEDD8 positions the active
site via interactions more than 30 A˚ away, by coordinating
RBX1’s N-terminal strand anchored to CUL1, the subsequent
linker, and C-terminal RING domain (Figures 4A–4C). RBX1’s
linker contacts NEDD8 and aids the RING in stabilizing the
closed UBC12NEDD8 conformation. Perhaps more impor-
tantly, the linker is reciprocally regulated by the donor NEDD8.
The carbonyl from NEDD8’s Lys33 forms a hydrogen bond
with the amide from RBX1’s Val38, and the backbone spanning
NEDD8’s Glu34 to Gly35 makes van der Waals contacts with
RBX1’s Ile37 to rigidify RBX1’s linker into a unique conformation
that has not been previously observed.
Here, NEDD8 essentially ‘‘pushes’’ on the RBX1 linker, which
in turn acts as a lever that positions the RING-UBC12NEDD8
portion of the complex (Movie S2). As a result, NEDD8 directs
juxtaposition of the UBC12NEDD8 active site and CUL1’s
acceptor site. In agreement with this important role as a lever,
mutation of Ile37 to Ala or simultaneous mutation with Val38 to
Gly impairs cullin neddylation, whereas there is no effect of indi-
vidual side chain replacements for the adjacent Asp36 or Val38
(Figure 4D).
The distal border of the NEDD8 binding site is RBX1’s Trp35,
which is the pivot around which the linker and RING rotate in
different RBX1-cullin complex structures (Figure 4A; Movie S2).
In the neddylation complex, RBX1’s Trp35 is enwrapped by
side chains from NEDD8’s Glu31 and Glu32 (Figures 4B and
4C). Consistent with the structure, mutation of Trp35 to Ala,
Tyr, or Phe, which would be tolerated by the donor NEDD8,
only slightly decreases NEDD8 ligation to a cullin, whereas
mutation to Asp, which would repel NEDD8’s Glu31 and 32, is
deleterious (Figure 4E).
The RBX1 Pivot Disfavors CUL1 Targeting by UB
The structure provides a rationale for why the UBL, rather than
E2, is critical for switching RBX1 RING E3 specificity toward
CUL1 (Figures 1D and 1E). Notably, this is not dictated by directCell 157, 1671–1684, June 19, 2014 ª2014 Elsevier Inc. 1675
Figure 3. RING-E2UBL-Acceptor Modules for Neddylation
(A) Different RING-E2UBL closed conformations shown with the E2 catalytic core domain aligned for RBX1-UBC12NEDD8-CUL1CTD-DCN1P and CBL-
UBCH5UB (Dou et al., 2013).
(B) Close-up of E2UBL interfaces from (A).
(C) Variation in E2UBL interfaces shown with UBLs aligned from RBX1-UBC12NEDD8-CUL1CTD-DCN1P and CBL-UBCH5UB.
(D) Pulse-chase assays for compensation between UBC12 Leu mutants and NEDD8 I44A in RBX1-mediated CUL1 modification.
(E) Pulse-chase assays testing compensation between UBCH5 Leu mutant and UB I44A in RBX1-mediated CUL1 modification.
(F) Different RING-E2UBL active site presentations highlighted by relative placement of UBC12 D143 and UBCH5B D117 side chains, viewed with UBLs aligned
fromRBX1-UBC12NEDD8-CUL1CTD-DCN1P (CUL1acceptorK720modeled in placeof Arg) andCBL-UBCH5UB.UBC12D143carbonyl is also shown in sticks.
(G) Different E2UBL active site presentations in UBC12NEDD8-CUL1 and UBC9-SUMORANGAP1 (Reverter and Lima, 2005), oriented by aligning UBC9 on
UBCH5 from (F), and highlighting different relative positions of UBC12 D143 and UBC9 D127. UBC12 D143 carbonyl is also shown in sticks.
(H) RBX1-mediated pulse-chase fluorescent NEDD8 transfer from UBC12 to CUL1CTD testing roles of side chains from RBX1’s N113, which aligns NEDD8’s
C-terminal tail, and D143, opposite the UBC12NEDD8 bond.
(I) RBX1’s distinct linchpin Arg46 in spheres, shifted across RING domain from location of canonical linchpin as typified in CBL. RING-E2UBL portions of RBX1-
UBC12NEDD8-CUL1CTD-DCN1P and CBL-UBCH5UB structures shown with UBLs aligned.
(J) Linchpins (blue) in human RING domain sequences. Red, zinc ligands; green, E2-binding residue; purple, RBX1 pivot; yellow, lever.
(K) RBX1-mediated pulse-chase fluorescent NEDD8 transfer from UBC12 to CUL1CTD testing role of RBX1 R46 linchpin.
(L) Pulse-chase assays testing role of NEDD8’s Leu8 and Thr9 from the b1-b2 loop in RBX1-mediated transfer from UBC12 to CUL1CTD.
See also Figure S2.
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contacts between the donor NEDD8 and its target, CUL1.
Rather, specificity comes from distinctive features of NEDD8’s
interactions with RBX1’s pivot and lever, which position the
RBX1-UBC12NEDD8 assembly. NEDD8 residues that differ
from UB and contact RBX1 are the above mentioned Glu31
and Glu32, which correspond to UB’s Gln31 and Asp32 (Fig-
ure 4C). Despite seemingly subtle side chain differences, the
aliphatic portion of NEDD8’sGlu32makes hydrophobic contacts
with RBX1’s Trp35 pivot, whereas UB’s shorter Asp32 would
repel the Trp35 pivot. Also, the hydrogen bond from NEDD8’s
Glu31 to RBX1’s Trp35 side chain would be less favored by
UB’s Gln31. Indeed, shortening the pivot with RBX1 W35A,
W35Y, and W35F mutations relieve repulsion and increase UB
ligation to CUL1CTD (Figure 4F). Swapping identities of residues
31 and 32 is sufficient to transform the efficiencies of RBX1-
mediated NEDD8 or UB ligation to CUL1CTD from UBC12 and
UBCH5 (Figures 4G and 4H). The data suggest that subtle side
chain differences between NEDD8 and UB orient the Trp35 pivot
to direct the E2UBL catalytic center toward CUL1, thereby pro-
moting neddylation (Figure 4I).
Following neddylation, UBC12 would be released so RBX1
could bind an E2UB intermediate for UB ligation to an F-box-
protein bound target (Duda et al., 2011; Zimmerman et al.,
2010). This shift in substrate preference upon neddylation of
CUL1-RBX1 ismanifested in a pulse-chase assay for UB transfer
from UBCH5 to a Cyclin E phosphopeptide bound to the F-box
protein FBW7DD (Figure 4J) (Duda et al., 2012; Hao et al.,
2007). Although there is no structure of a neddylated SCF medi-
ating UB ligation to a substrate, our data indicate requirement for
a conformational change: the immediate product of NEDD8 liga-
tion would resemble the RBX1-UBC12NEDD8-CUL1-DCN1
structure, except with NEDD8’s covalent linkage transferred to
CUL1 and UBC12 released. Modeling a RING-UBCH5UB
structure on RBX1’s RING shows clashing between the donor
UB and NEDD8CUL1 (Dou et al., 2012b, 2013; Plechanovova´
et al., 2012; Pruneda et al., 2012) (Figure S3A). This provides
a rationale for conformational flexibility observed in prior
NEDD8-CUL5CTD-RBX1 structures, in which the RBX1 RING
and NEDD8-linked CUL1 WHB domain appear to swing around
relative to each other, via several points of rotation (Figures S3B
and S3C) (Duda et al., 2008).
Given this conformational freedom, we wondered why UB is
not substantially ligated to neddylated CUL1 and asked if this
involves UB repelling RBX1’s pivot in a neddylated CRL. In
ubiquitination assays with the RBX1 W35A mutation, or with
UB bearing the ‘‘neddylizing’’ D31E and Q32E mutations,
NEDD8CUL1 undergoes ubiquitination, with a concomitant
decrease in UB ligation to the SCF substrate Cyclin E (Figure 4J).
However, use of RBX1 with an I37A mutation in the ‘‘lever’’ elim-
inated NEDD8CUL1 targeting by the ‘‘neddylized’’ UB, without
substantially impacting SCF-bound Cyclin E ubiquitination
(Figure 4K).
The simplest explanation for the data is that a neddylated CRL
is sufficiently flexible to allow self multi- or polyubiquitination,
confirmed by mass spec (Figure S3D). However, an E2-linked
donor UB is deflected from NEDD8CUL1 by UB’s residues
31 and 32 and RBX1’s Trp35. Also, F-box protein-bound sub-
strate ubiquitination does not require RBX1’s Ile37. With UBmutated to resemble NEDD8, UBCH5UB Q31E/D32E likely
binds RBX1 as in the neddylation intermediate. This includes
interactions between the donor ‘‘neddylized’’ UB and RBX1’s
‘‘Ile37 lever,’’ which stabilize and position the activated
UBCH5UB in such a way that the active site accesses lysines
from NEDD8CUL1 and its linked UB. With RBX1’s Ile37
mutated, a catalytic structure mimicking RBX1-UBC12NEDD8
is unattainable, while elements required for CRL substrate ubiq-
uitination remain. Future studies will be required to visualize a
neddylated CRL in the act of ligating UB to a substrate.
CUL1 Structurally Licenses Acceptor Lys for Projection
into UBC12NEDD8 Active Site
Two key CUL1 features influence selection of the Lys720
acceptor. First, surface complementarity between CUL1 and
UBC12 enables their juxtapositioning and explains why nearby
lysines failed to rescue CUL1 K720A neddylation (Figures 1G,
2, 5A, and S1D). Accordingly, deleting the two C-terminal resi-
dues that contribute to this interface, or imposing a barrier by
fusing CUL1’s Ala776 to cyan-fluorescent protein or a Myc-tag
impairs neddylation (Figure 5B).
Second, ligation can be driven by projection of a structurally
ordered acceptor Lys into the active site of an E2UBL interme-
diate. Whereas a prior study of SUMOylation identified E2 resi-
dues guiding the acceptor Lys (Yunus and Lima, 2006), we find
the CUL1 substrate contributing to this role in neddylation.
CUL1’s Tyr774 aligns and directs CUL1’s acceptor (here an
Arg, but normally Lys720) into the active site (Figure 5A). The
importance of rigid support for CUL1’s acceptor Lys720 is veri-
fied by wild-type neddylation with a Y774F mutant, which could
maintain stacking even without a terminal hydroxyl (Figure 5C).
By contrast, neddylation is impaired by the smaller Y774A sub-
stitution, the somewhat flexible Y774M mutant, or the too bulky
Y774W mutant that would reposition Lys720. Thus, the sub-
strate—CUL1—plays a role in licensing its acceptor Lys720 by
structurally supporting projection into the UBC12NEDD8
active site.
DCN1 Synergizes with RBX1-UBC12NEDD8-CUL1
Catalytic Architecture
The structure reveals how DCN1 stimulates NEDD8 ligation in a
manner that depends on RBX1 RING activity. Intriguingly, there
are no apparent contacts between DCN1P and RBX1. Rather,
DCN1P and CUL1-RBX1-UBC12NEDD8 are optimized to
interact in the catalytic architecture. DCN1P increases recruit-
ment of UBC12 to CUL1-RBX1 by engaging both CUL1’s WHB
and UBC12’s acetylated N terminus (Scott et al., 2011) (Fig-
ure 6A). Flexibility of some residues connecting UBC12’s N
terminus and catalytic domain, reflected by lack of electron den-
sity, might imply that DCN1 engages the RBX1-RING-bound
UBC12NEDD8 and CUL1 in several different relative orienta-
tions. However, docking DCN1 and the activated RBX1 RING-
UBC12NEDD8 on prior CUL1-RBX1 structures reveals
substantial clashing (Figures 6B and 6C) (Angers et al., 2006;
Calabrese et al., 2011; Duda et al., 2008; Fischer et al., 2011;
Goldenberg et al., 2004; Zheng et al., 2002). Although rotation
could allow RBX1’s RING to bind and activate UBC12NEDD8
in alternative RING orientations, docking models with RINGCell 157, 1671–1684, June 19, 2014 ª2014 Elsevier Inc. 1677
Figure 4. NEDD8 Pushes an RBX1 Lever and Directs an RBX1 Pivot to Juxtapose the Active Site and Acceptor Lys
(A) RBX1 RING domain andW35 ‘‘pivot’’ positions in neddylation complex compared with CUL1-RBX1-CAND1 (Goldenberg et al., 2004; Zheng et al., 2002), with
CUL1 aligned.
(B) Close-up of contacts between UBC12-linked donor NEDD8 and RBX1 linker. Zinc atoms bound to RING are shown as spheres.
(C) As in (B) except with NEDD8 in surface colored by identity with UB. RING and UBC12-binding residues are identical between NEDD8 and UB (yellow), but
exposed surfaces and contacts to RBX1 pivot differ (orange).
(D) Comparison of effects of Ala mutations in place of RBX1 ‘‘lever’’ (I37) or other linker residues in RBX1-mediated NEDD8 transfer from UBC12 to CUL1CTD.
Graph, rate compared to WT RBX1; error, 1 SD.
(E) Same as (D) but with variants of RBX1 Trp35 pivot.
(F) Same as (E) but monitoring fluorescent UB transfer from UBCH5B.
(G) Immunoblot comparing RBX1-mediated transfer of WT NEDD8, or variants with corresponding E31Q and E32D from UB, from UBC12 to CUL1CTD. Graph,
rate compared to WT UBC12NEDD8; error, 1 SD.
(H) RBX1-mediated transfer of fluorescent UB, or ‘‘neddylized’’ variants with Q31E and D32E, from UBCH5B to CUL1CTD. Graph, rate compared to WT
UBCH5UB; error, 1 SD.
(legend continued on next page)
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Figure 5. CUL1 Features Contributing to NEDD8 Acceptor Lys Selection
(A) Close-up of complementary UBC12-CUL1 interface. Note UBC12 proximity to CUL1’s C terminus and interactions with carbonyl from CUL1’s penultimate
Leu775. Tyr774 structurally aligns CUL1’s Lys720, even in the absence of neddylation enzymes as in superposition of prior CUL1 WHB domain structures.
(B) Role CUL1 C terminus forming a complementary surface with UBC12, assayed by pulse-chase RBX1-mediated transfer of fluorescent NEDD8 fromUBC12 to
the indicated CUL1CTD C-terminal deletion or extension variants. Graph, rate compared to CUL1; error, 1 SD.
(C) Effects of substituting the CUL1 Lys720 stabilizing residue Tyr774 in experiments as in (B).positions in a neddylated CUL-RBX1 (Duda et al., 2008) would
place UBC12’s N terminus too far away from DCN1-CUL1 (Fig-
ure 6D). Thus, modeling suggests DCN1 tethers RBX1-bound
UBC12NEDD8 to CUL1 to synergize with the catalytic RBX1-
UBC12NEDD8-CUL1 architecture. Accordingly, I37A and
I37D mutations in the ‘‘lever’’ decrease DCN1-dependent
NEDD8 ligation to a cullin’s C-terminal domain, as does a donor
UB that repels the RBX1 pivot (Figures 6E–6G).
Reactivity of E2UBL Intermediate Is Triggered by
Properly Positioned Acceptor Lys
An additional factor potentially influencing reactivity of an
E2UBL intermediate emerged from our efforts to trap a stable
complex for crystallography. Thioester linkages are optimally
reactive toward properly positioned primary amines. Accord-
ingly, adding RBX1-CUL1 to thioester-linked UBC12NEDD8
results in rapid NEDD8 ligation to CUL1 (Figures S4A
and S4B). Comparatively, ligation from oxyester-linked
UBC12NEDD8 is slowed, and only a fraction of NEDD8 is
ligated to CUL1. The majority of the oxyester-linked
UBC12NEDD8 undergoes hydrolysis, discharging NEDD8 to
solvent (Figures 7A and 7B). We do not know if the differences
in substrate partitioning arise from subtle structural variations
between the thioester and oxyester-linked complexes, or
because an ester has expanded potential to react with 55 M
water over an amine. Nonetheless, the relatively greater potential
for the oxyester-linked complex to discharge via hydrolysis
versus aminolysis offered the opportunity to assay for a role of
the target lysine in stimulating reactivity of a UBC12NEDD8
intermediate.(I) Schematic of roles and orientations of RBX1 elements and interactions w
UBC12NEDD8-CUL1CTD-DCN1P.
(J and K) Pulse-chase assays for NEDD8-modifed SCFFbw7DD testing roles of RBX1
UB from UBCH5B to either an F-box-bound substrate (Cyclin E phosphopeptide
See also Figure S3 and Movie S2.Consistent with studies showing that RING E3-E2UBL inter-
mediates are activated for nucleophilic attack, RBX1-CUL1CTD
harboring a K720A substitution stimulated hydrolysis of the
oxyester-linked UBC12NEDD8. Intriguingly, however, this
discharge was massively accelerated in the presence of the
CUL1 acceptor Lys720 (Figure 7B). Several observations
suggest that the target Lys influences reactivity of the
UBC12NEDD8 bond. First, adding DCN1P to support juxtapo-
sition of the active site and CUL1 target Lys720 increased both
NEDD8 ligation to CUL1 and hydrolysis of the oxyester-linked
UBC12NEDD8 intermediate (Figures 7C and 7D). As with
DCN1P-independent reactivity, DCN1P-dependent hydrolysis
was stimulated byCUL1’s Lys720. Second, the levels of hydroly-
sis correlate with projection of CUL1’s Lys720 to the active site,
as probed by mutations for CUL1 Tyr774 (Figures 7C and 7D).
Third, stimulation by the acceptor Lys depends on a known
catalytic element: hydrolysis is slowed with a Ser substitution in
place of the E2 ‘‘catalytic Asn’’ (Figure S4C) (Wu et al., 2003b),
which ultimately enabled crystallizing the neddylation complex.
Notably, the effect of the acceptor Lys is not restricted to
UBC12: reactivity of an oxyester-linked UBCH5UB intermedi-
ate is also stimulated through features that support projecting
the CUL1 target Lys720 into the catalytic center of the activated,
conformationally closed E2UB intermediate. CUL1’s Lys720
stimulates hydrolysis for the oxyester-linked UBCH5 complex
with UB Q31E/D32E, where NEDD8-like interactions with the
RBX1 lever and pivot can stabilize the catalytic architecture
and juxtaposition the E2UBL intermediate and CUL1 target.
Furthermore, hydrolysis is decreased by the CUL1 Y774M
mutant, with lesser effects for Y774F. In contrast, both ligationith UBC12NEDD8, oriented as in prior RBX1-CUL1 structures or RBX1-
W35 ‘‘pivot’’ (J) and I37 ‘‘lever’’ (K) in directingWT or ‘‘neddylized’’ Q31E/D32E
) or neddylated CUL1.
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Figure 6. DCN1P Synergizes with Catalytic
RBX1-UBC12NEDD8-CUL1 Architecture
to Promote Neddylation
(A) RBX1-UBC12NEDD8-CUL1CTD-DCN1P
structure, highlighting complementarity of
NEDD8’s surface with structure of RBX1 and
UBC12 core domain, and unstructured UBC12
region linking UBC12’s catalytic E2 core domain
with the acetylated N terminus bound to DCN1P.
(B) Incompatibility of DCN1-UBC12NEDD8
binding to RBX1-CUL1-CAND1 due to NEDD8
clashing with RBX1 andCUL1.Model generated by
docking RING domains from the present and prior
1U6G Protein Data Bank (PDB) structures, with
RBX1NTD-CUL1CTD oriented as in (A).
(C) Incompatibility of DCN1-UBC12NEDD8
binding to RBX1-CUL1 in conformation from 3RTR
PDB due to NEDD8 clashing with RBX1-CUL1, and
DCN1-UBC12 clashing with RBX1. Model gener-
ated by docking RING domains from the present
and prior 3RTR PDB structures, with RBX1NTD-
CUL1CTD oriented as in (A).
(D) Incompatibility of DCN1-UBC12NEDD8
binding to RBX1-CUL1NEDD8 in conformation
from 3DQV PDB due to too great a distance be-
tween UBC12’s N terminus bound to DCN1 and
UBC12’s core domain bound to RBX1 RING. Ori-
ented with RBX1NTD-CUL1CTD as in (A).
(E) Mutations testing role of RBX1 ‘‘lever’’ I37 in
rapid quench-flow pulse-chase NEDD8 transfer
fromUBC12 toCUL1CTD in thepresenceor absence
of DCN1P. NEDD8 detected by immunoblot.
(F) Mutations testing role of UBL identity (fluo-
rescent ‘‘neddylized’’ [Q31E/D32E/R72A] or UB
[R72A]) in transfer from UBC12 to CUL1CTD-RBX1
in the presence or absence of DCN1P, in rapid
quench-flow pulse-chase assay. The UB R72A
mutationallows loadingonUBC12 inpulse reaction.
(G) Role of UBL identity (fluorescent NEDD8 or UB
[R72A]) in transfer from UBC12 to CUL2CTD-RBX1
in the presence or absence of DCN1P.and hydrolysis are slow (hours versus minutes), and there is
no obvious effect of CUL1’s Lys720 for the oxyester-linked
complex with wild-type UB, which repels RBX1’s pivot (Figures
7E and 7F).1680 Cell 157, 1671–1684, June 19, 2014 ª2014 Elsevier Inc.The data imply that the target Lys may
toggle the E2UBL active site, either
indirectly or directly. The target Lys
could potentially help hold the RING-
UBC12NEDD8 assembly in the acti-
vated position, which in turn stabilizes
the closed UBC12NEDD8 conformation
that immobilizes the oxyester (and pre-
sumably thioester) bond to increase reac-
tivity. It is also possible that insertion of
the target Lys modulates the structure of
the UBC12NEDD8 active site. Indeed,
superimposing various UBC12 structures
reveals potential fluctuation in the loop
clamping NEDD8’s C terminus andCUL1’s target site into the active site (Figure S4D). Irrespective
of the mechanism, it seems likely that projection of CUL1’s
acceptor Lys720 into the catalytic center tweaks the
UBC12NEDD8 active site and stimulates reactivity.
Figure 7. Potential for CUL1’s Acceptor Lys720 to Toggle E2UBL Reactivity and Summary of Elements Contributing to Neddylation
(A) Mechanisms discharging an E2UBL intermediate such as UBC12NEDD8. Reaction with an acceptor Lys leads to ligation. Reaction with solvent leads to
hydrolysis of the intermediate.
(B) Role of CUL1-RBX1 and CUL1’s acceptor K720 on reactivity of oxyester-linked UBC12 (C111S)NEDD8 complex, as assayed by hydrolysis and detected by
Coomassie-stained SDS-PAGE.
(C and D) Role of factors influencing proper placement of CUL1 acceptor K720 (absence/presence of DCN1P; replacements for Y774) on reactivity of oxyester-
linked UBC12 (C111S)NEDD8.
(E and F) Role of factors influencing placement of RBX1-activated UBCH5UB toward CUL1 acceptor K720 (WT UB or ‘‘Neddylized’’ Q31E/D32E that orients the
RBX1 ‘‘pivot’’) on reactivity of oxyester-linked UBCH5B (C85S)UB, as assayed by hydrolysis. Note timescales (hr versus min).
(G) Mechanisms influencing reactivity and enzyme conformation that together drive neddylation and establish specificity for the multifunctional RING E3 RBX1.
See also Figure S4.DISCUSSION
Multimodal Mechanism for RING E3 Ligation and
Specificity
A fundamental question in protein regulation is: how is a partic-
ular UBL matched with a specific target? We provide, to ourknowledge, the first structure of a RING E3-E2UBL-substrate
complex representing a ligation intermediate. Similarity among
RING-E2UBL structures and E2UBL-substrate complexes
suggest overall related mechanisms of neddylation, ubiquitina-
tion, and SUMOylation, with distinct features establishing UBL
and acceptor Lys specificity. We found that for neddylation,Cell 157, 1671–1684, June 19, 2014 ª2014 Elsevier Inc. 1681
the catalytic modules are not optimized to function indepen-
dently; instead, conformational activation of a RING-E2UBL
intermediate, stimulation of E2UBL reactivity, and acceptor
lysine recognition are intertwined.
Numerous mechanisms contribute to NEDD8 ligation and
specificity (Figure 7G): (1) RBX1 uses a unique linchpin for
RING-mediated allosteric activation of the UBC12NEDD8 in-
termediate, (2) RBX1 and UBC12NEDD8 regulate each other,
with the RBX1 linker and RING synergizing to stabilize the
closed, activated UBC12NEDD8 conformation, and NEDD8
reciprocally pushing the RBX1 linker lever to steer the active
site to CUL1’s acceptor, (3) the unique UBC12NEDD8 closed
conformation presents a distinctive active site configuration to
the acceptor Lys, (4) shape complementarity at the UBC12-
CUL1 interface targets the CUL1 acceptor, (5) CUL1 structure
licenses the acceptor Lys in an extended conformation, (6)
DCN1 tethers UBC12 to CUL1 in the catalytic architecture for
neddylation, and (7) the CUL1 acceptor Lys toggles E2UBL
reactivity. Also, misdirected UB ligation to a cullin by the multi-
functional RBX1 is prevented by (1) CDC34 structure (Huang
et al., 2014) being incompatible with architecture for CUL1
modification, (2) RBX1 having a suboptimal linchpin for
UBCH5UB, and (3) UB repelling the RBX1 pivot, thereby de-
flecting RBX1’s RING from targeting CUL1.
Specificity among Seemingly Similar Catalytic Modules
The RBX1-UBC12NEDD8-CUL1CTD-DCN1P and prior struc-
tures provide insights into how specificity is established for
similar RING E3-E2 catalytic modules. Diversity in RING-
E2UBL geometries influences interactions with acceptor
lysines (Figures 3F, 3G, 7G, and S4D) (Dou et al., 2012b, 2013;
Plechanovova´ et al., 2012; Pruneda et al., 2012; Reverter and
Lima, 2005). Each E2UBL combination is activated through its
own closed conformation, with different angles between the E2
and UBL globular domain achieved by a variety of mechanisms.
MultifunctionalRINGE3smayusedifferent or evenmultiple linch-
pins to cement their various E2UBL partners. RBX1’s Arg46
linchpin enables distinctive RING-E2 contacts and may support
CDC34UB as well as UBC12NEDD8. However, the ‘‘canoni-
cal’’ linchpin Asn98 contributes to ubiquitination byUBCH5UB,
and suboptimal activation by Asn98 relative to Arg is one factor
favoring NEDD8 over UB modification of CUL1. It seems likely
that inmultifunctional E3s,RINGsequences reflect compromises
to direct many E2UBL partners toward their specific targets,
rather than optimization of some functions.
Although a variety of ligation mechanisms have been pro-
posed, common features include placement and deprotonation
of the acceptor Lys within the active site and stabilization of
the negatively charged transition state arising from Lys attack
of the E2UBL intermediate (Komander and Rape, 2012). Prior
studies had implicated an E2 or substrate Asp in either guiding
the acceptor Lys into the active site, or directly mediating depro-
tonation via ion-pairing (Plechanovova´ et al., 2012; Wickliffe
et al., 2011; Yunus and Lima, 2006). For neddylation, the sub-
strate and E2 both guide the acceptor Lys to the UBC12 active
site without obvious acidic groups, and the corresponding
Asp143 neither contacts the acceptor nor is required for ligation.
Instead, the RBX1-UBC12NEDD8-CUL1CTD-DCN1P structure1682 Cell 157, 1671–1684, June 19, 2014 ª2014 Elsevier Inc.is consistent with a mechanism for deprotonation akin to that
proposed for SUMOylation, whereby CUL1 Lys720 contacts
with elements dispersed throughout UBC12’s active site—
perhaps the backbone carbonyl of Asp143 or other carbonyls
within the same loop, and/or the thioester bond itself—replace
interactions between the ε-amino group and a proton from
bulk solvent (Yunus and Lima, 2006). These same interactions
may enable CUL1’s Lys720 to reciprocally stabilize the catalytic
architecture to activate UBC12. Although future studies will be
required to visualize the ensuing intermediate, we note that
UBC12’s so-called ‘‘catalytic Asn’’ (Ser103 in the structure)
would be ideally poised to stabilize the intermediate and sur-
rounding active site loops in UBC12 (Figure S4E) (Wu et al.,
2003b).
Integration of E3-E2UBL-Target Modules by UBL-
Guided Lever and Acceptor Lys Switch
A key finding is that the overall architecture and catalytic activity
are influenced by substrates. The donor UBL NEDD8 steers its
RING E3, RBX1, to position the active site at the acceptor (Fig-
ure 4). RBX1’s linker stabilizes the activated UBC12NEDD8
conformation in a manner analogous to non-RING elements
priming the closed conformation of UBCH5UB (Dou et al.,
2012b, 2013; Plechanovova´ et al., 2012). The NEDD8-RBX1
linker interaction reciprocally positions the catalytic machinery
to juxtapose the RING-UBC12NEDD8 catalytic center and
CUL1 acceptor (Figure 4). Thus, the donor UBL dictates target-
ing specificity allosterically. Subtle side chain differences be-
tween NEDD8 and UB—E31Q and E32D—repel an RBX1 pivot
and divert the RBX1 RING E3 from CUL1.
Specificity is also imparted by the substrate, with CUL1 com-
plementing UBC12’s surface and projecting the acceptor
Lys720 into the active site (Figures 5 and 7). E2-substrate
interactions are reciprocal, with the properly positioned CUL1
acceptor Lys720 toggling reactivity of a covalent (albeit
oxyester-linked) UBC12NEDD8 or UBCH5’’neddylized’’ UB
complex. DCN1P further synergizes with the active architecture
(Figure 6). Thus, all components of the RBX1-UBC12NEDD8-
CUL1-DCN1 intermediate provide elements that interlock, with
RBX1-UBC12NEDD8 resembling a spring ready to discharge
and CUL1’s Lys720 a trigger for the reaction. In this way, optimal
catalysis is integrated with UBL and acceptor targeting
specificity.
Principles underlying neddylation also may apply to CRL-
mediated ubiquitination. Although a ‘‘lever’’ directing RBX1
RING-E2UB to ubiquitination targets remains to be identified,
we speculate that NEDD8, CUL1, an F-box protein-bound sub-
strate, or other E3 or E2 features could help steer the active
site toward a ubiquitination target. For example, the E2 CDC34
has distinctive acidic loops and a C-terminal tail that may coor-
dinate the donor or acceptor UB and anchor the RBX1-CDC34-
UBorientation for target ubiquitination, much like DCN1 restrains
the orientation of RBX1 RING-activated UBC12NEDD8 toward
CUL1 (Choi et al., 2010; Kleiger et al., 2009a; Petroski and De-
shaies, 2005; Spratt and Shaw, 2011; Ziemba et al., 2013).
Other RING E3-E2 ligases probably also achieve specificity by
the acceptor and UBL modulating enzyme conformation and
reactivity. Many E2UBL intermediates may be toggled by the
acceptor lysine, particularly as a modeled CUL1 acceptor lysine
contacts a UBC12 loop (Figure S4D) that is dynamic in other E2s
(Berndsen et al., 2013; Dou et al., 2012b; Yunus and Lima, 2006).
Several RING E3s couple substrate binding with E2UB acti-
vation (Du et al., 2002; Mattiroli et al., 2014; Rojas-Fernandez
et al., 2014). Also, other E3s undergo RING domain rotation to
achieve activity, and for IAP and CBL E3s, the interdomain
linkers that move during RING rotation stabilize the activated
UBCH5UB closed conformation by contacting UB (Dou et al.,
2012a, 2012b, 2013; Dueber et al., 2011; Kobashigawa et al.,
2011). For these and other RING E3s, we anticipate future
studies will reveal that the E2-bound donor UB reciprocally sta-
bilizes active architectures, steering the associated E2 active site
toward ubiquitination substrates much like NEDD8 steers its
linked E2 via interaction with RBX1’s linker ‘‘lever.’’ The stage
is now set for broadly understanding how targets and UBLs
serve as switches by toggling E3/E2 conformations to establish
ligation specificity.
EXPERIMENTAL PROCEDURES
Protein Expression
Proteins are human and were expressed either untagged or as GST- or His-
fusions in Escherichia coli or insect cells and purified as described (Calabrese
et al., 2011; Duda et al., 2012; Huang et al., 2009; Scott et al., 2011). Assays
with DCN1 used insect cell expressed N-terminally acetylated UBC12 (Scott
et al., 2011). See the Extended Experimental Procedures for details.
Crystallography
The crystal structure used UBC12 (N-acetylated, N103S, C111S)NEDD8
linked by an oxyester bond and stabilized by an E2 catalytic Asn mutation.
UBC12 variant (60 mM), APPBP1-UBA3 (4 mM), and NEDD8 (80 mM) were incu-
bated in 25 mM HEPES, 200 mM NaCl, 2.5 mM MgCl2, 1 mM ATP, pH 7.5,
30C for 18 hr. UBC12NEDD8 was purified by ion exchange and gel filtration
chromatography. UBC12NEDD8, RBX1-CUL1CTD (K720R), and DCN1P were
mixed at 40 mM:35 mM:40 mM and crystals grown in 4C hanging drops in
z20% PEG3350, 0.2 M ammonium citrate, pH 7.0 with seeding, and cryopro-
tected by soaking in mother liquor with 12% and then 24% ethylene glycol.
Data were collected at APS ID-24E. The structure was determined by molec-
ular replacement. See the Extended Experimental Procedures for details.
Enzyme Assays
Pulse-chase assays exclusively monitoring the ligation reaction were adapted
from (Scott et al., 2011) for UBL detection by fluorescence or immunoblotting.
Indicated E2UBL complexes were formed in the pulse reaction. After
quenching the pulse, UBL was ‘‘chased’’ from E2 by adding variants of
RBX1-CULCTD (Figures 1, 3, 4, 5, 6, 7, S1, and S4), neddylated SCF compo-
nents and CyclinE peptide (Figures 4J, 4K, and S2), or RBX1-CULCTD and
DCN1P (Figures 6E–6G, 7D, and S4), as indicated. Aliquots were taken at
different times and products separated by SDS-PAGE and visualized by fluo-
rescence or immunoblot. See the Extended Experimental Procedures for
details.
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